VSee Health, Inc. (VSEE)
NASDAQ: VSEE · Real-Time Price · USD
0.285
+0.005 (1.79%)
At close: Mar 9, 2026, 4:00 PM EDT
0.280
-0.005 (-1.72%)
After-hours: Mar 9, 2026, 5:05 PM EDT
VSee Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 14.43 | 10.42 | 5.77 | 6.38 | 7.34 | 6.8 |
| Revenue Growth (YoY) | 77.78% | 80.74% | -9.59% | -13.08% | 7.83% | - |
| Cost of Revenue | 6.52 | 3.24 | 1.93 | 1.54 | 1.41 | 1.34 |
| Gross Profit | 7.9 | 7.18 | 3.83 | 4.84 | 5.92 | 5.46 |
| Selling, General & Admin | 16.99 | 11.86 | 5.62 | 6.3 | 5.67 | 5.06 |
| Operating Expenses | 16.99 | 11.86 | 5.62 | 6.3 | 5.67 | 5.06 |
| Operating Income | -9.09 | -4.68 | -1.79 | -1.46 | 0.25 | 0.4 |
| Interest Expense | -1.47 | -0.21 | -0.19 | -0.03 | - | -0.05 |
| Interest & Investment Income | - | - | - | - | - | 0 |
| Other Non Operating Income (Expenses) | 0.74 | 3.66 | 0.07 | 0.09 | 0 | - |
| EBT Excluding Unusual Items | -9.82 | -1.23 | -1.91 | -1.4 | 0.25 | 0.36 |
| Merger & Restructuring Charges | -0.08 | -0.79 | -0.09 | -0.22 | - | - |
| Impairment of Goodwill | - | -56.68 | - | - | - | - |
| Other Unusual Items | -0.13 | -0.65 | 0.11 | - | 0.13 | - |
| Pretax Income | -10.03 | -59.34 | -1.89 | -1.62 | 0.39 | 0.36 |
| Income Tax Expense | 0.04 | -1.64 | 1.84 | -0.69 | 0.11 | 0.1 |
| Earnings From Continuing Operations | -10.07 | -57.7 | -3.73 | -0.93 | 0.28 | 0.26 |
| Minority Interest in Earnings | - | - | -0.04 | 0.09 | 0.2 | - |
| Net Income | -10.07 | -57.7 | -3.76 | -0.84 | 0.48 | 0.26 |
| Net Income to Common | -10.07 | -57.7 | -3.76 | -0.84 | 0.48 | 0.26 |
| Net Income Growth | - | - | - | - | 83.83% | - |
| Shares Outstanding (Basic) | 16 | 10 | 10 | 10 | 10 | 10 |
| Shares Outstanding (Diluted) | 16 | 10 | 10 | 10 | 10 | 10 |
| Shares Change (YoY) | 85.69% | 2.15% | - | 0.53% | 0.99% | - |
| EPS (Basic) | -0.62 | -5.65 | -0.38 | -0.08 | 0.05 | 0.03 |
| EPS (Diluted) | -0.62 | -5.65 | -0.38 | -0.08 | 0.05 | 0.03 |
| EPS Growth | - | - | - | - | 82.03% | - |
| Free Cash Flow | -4.52 | -5.84 | -0.64 | -0.83 | -0.46 | 0.79 |
| Free Cash Flow Per Share | -0.28 | -0.57 | -0.06 | -0.08 | -0.05 | 0.08 |
| Gross Margin | 54.78% | 68.87% | 66.47% | 75.81% | 80.74% | 80.30% |
| Operating Margin | -63.00% | -44.94% | -30.99% | -22.96% | 3.44% | 5.94% |
| Profit Margin | -69.81% | -553.69% | -65.26% | -13.11% | 6.49% | 3.80% |
| Free Cash Flow Margin | -31.34% | -56.08% | -11.05% | -12.95% | -6.27% | 11.60% |
| EBITDA | -6.48 | -3.36 | -1.79 | - | - | - |
| EBITDA Margin | -44.88% | -32.23% | -30.98% | - | - | - |
| D&A For EBITDA | 2.61 | 1.32 | 0 | - | - | - |
| EBIT | -9.09 | -4.68 | -1.79 | -1.46 | 0.25 | 0.4 |
| EBIT Margin | -63.00% | -44.94% | -30.99% | -22.96% | 3.44% | 5.94% |
| Effective Tax Rate | - | - | - | - | 27.98% | 27.98% |
| Revenue as Reported | 14.43 | 10.42 | 5.77 | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.